Moors & Cabot, Inc. Ark Genomic Revolution ETF (De Transaction History
Moors & Cabot, Inc.
- $1.96 Billion
- Q3 2024
A detailed history of Moors & Cabot, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Moors & Cabot, Inc. holds 7,961 shares of ARKG stock, worth $188,516. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,961
Previous 8,861
10.16%
Holding current value
$188,516
Previous $208,000
2.4%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$70 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$68.7 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$57.5 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.9 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39.8 Million0.03% of portfolio